Apolipoprotein E gene polymorphism is not a strong risk factor for diabetic nephropathy and retinopathy in Type I diabetes: Casecontrol study

BMC Medical Genetics

Volumn 2, Issue , 2001, Pages

  Shcherbak, Natalia S ^a  

^a PAVLOV FIRST SAINT PETERSBURG STATE MEDICAL UNIVERSITY   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; APOLIPOPROTEIN E2; APOLIPOPROTEIN E3; APOLIPOPROTEIN E4; DNA;

ADULT; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DIABETIC ANGIOPATHY; DIABETIC NEPHROPATHY; DIABETIC RETINOPATHY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC CODE; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; RISK FACTOR;

EID: 0344083841     PISSN: 14712350     EISSN: None     Source Type: Journal    
DOI: 10.1186/1471-2350-2-8     Document Type: Article

References (26)

1. Andersen AR, Christiansen JS, Andersen JK, Kreiner S, Deckert T: Diabetic nephropathy in Type 1 (insulin dependent) diabetes: an epidemiological study Diabetologia 1983, 25:496-501
2. Quinn M, Angelico MC, Warram JH, Krolewski AS: Familial factors determine the development of diabetic nephropathy in patients with IDDM Diabetologia 1996, 39:940-945
3. Utermann G, Langenbeck U, Beisiegel U, Weber W: Genetics of the apolipoprotein E system in man Am J Hum Genet 1980, 32:339-347
4. Zannis VI, Breslow JL: Human very low density lipoprotein apolipoprotein E isoprotein polymorphism is explained by genetic variation and posttranslational modification Biochemistry 1981, 20:1033-1041
5. Reilly SL, Ferrell RE, Kottke BA, Kamboh MI, Sing CF: The gender-specific apolipoprotein E genotype influence on the distribution of lipids and apolipoproteins in the population of Rochester, MN. I. Pleiotropic effects on means and variances Am J Hum Genet 1991, 49:1155-1166
6. Xhignesse M, Lussier-Cacan S, Sing CF, Kessling AM, Davignon J: Influences of common variants of apolipoprotein E on measures of lipid metabolism in a sample selected for health Arterioscler Thromb 1991, 11:1100-1110
7. Bickeboller H, Campion D, Brice A, Amouyel P, Hannequin D, Didierjean O, Penet C, Martin C, Perez-Tur J, Michon A, et al: Apolipoprotein E and Alzheimer disease: genotype-specific risks by age and sex Am J Hum Genet 1997, 60:439-446
8. Ukkola O, Kervinen K, Salmela PI, von Dickhoff K, Laakso M, Kesaniemi YA: Apolipoprotein E phenotype is related to macro- and microangiopathy in patients with non-insulin-dependent diabetes mellitus Atherosclerosis 1993, 101:9-15
9. Eto M, Horita K, Morikawa A, Nakata H, Okada M, Saito M, Nomura M, Abiko A, Iwashima Y, Ikoda A, et al: Increased frequency of apolipoprotein epsilon 2 allele in non-insulin dependent diabetic of (NIDDM) patients with nephropathy Clin Genet 1995, 48:288-292
10. Chowdhury TA, Dyer PH, Kumar S, Gibson SP, Rowe BR, Davies SJ, Marshall SM, Morris PJ, Gill GV, Feeney S, et al: Association of apolipoprotein epsilon2 allele with diabetic nephropathy in Caucasian subjects with IDDM Diabetes 1998, 47:278-280
11. Araki S, Moczulski DK, Hanna L, Scott LJ, Warram JH, Krolewski AS: APOE polymorphisms and the development of diabetic nephropathy in type 1 diabetes: results of case-control and family-based studies Diabetes 2000, 49:2190-2195
12. Diabetes Mellitus WHO Technical Report Series 1985, 727. World Health Organization, Geneva.
13. Jeppsson JO, Jerntorp P, Sundkvist G, Englund H, Nylund V: Measurement of hemoglobin Alc by a new liquid-chromatographic assay: methodology, clinical utility, and relation to glucose tolerance evaluated Clin Chem 1986, 32:1867-1872
14. Marre M, Claudel JP, Ciret P, Luis N, Suarez L, Passa P: Laser immunonephelometry for routine quantification of urinary albumin excretion Clin Chem 1987, 33:209-213
15. Hixson JE, Vernier DT: Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with Hhal J Lipid Res 1990, 31:545-548
16. Skobeleva NA, Vasina VI, Volkova MV, Sverdlova AM, Fomicheva EV, Obraztsova GI, Talalaeva EI, Shakir K, Laasri M, Vorontsov IM, et al: DNA polymorphism of the APOB100, APOCIII, APOE, and angiotensin-converting enzyme genes and indicators of the lipid spectrum in children and adolescents in St. Petersburg Mol Gen Mikrobiol Virusol 1997, 4:36-40
17. Heesom AE, Hibberd ML, Millward A, Demaine AG: Polymorphism in the 5′-end of the aldose reductase gene is strongly associated with the development of diabetic nephropathy in type I diabetes Diabetes 1997, 46:287-291
18. Doria A, Warram JH, Krolewski AS: Genetic predisposition to diabetic nephropathy. Evidence for a role of the angiotensin I - converting enzyme gene Diabetes 1994, 43:690-695
19. Ha SK, Seo JK: Insertion/deletion polymorphism in ACE gene as a predictor for progression of diabetic nephropathy Kidney Int Suppl 1997, 60:S28-S32
20. Fogarty DG, Zychma MJ, Scott LJ, Warram JH, Krolewski AS: The C825T polymorphism in the human G-protein beta3 subunit gene is not associated with diabetic nephropathy in Type I diabetes mellitus Diabetologia 1998, 41:1304-1308
21. Siffert W: G protein beta3 subunit 825T allele, hypertension, obesity, and diabetic nephropathy Nephrol Dial Transplant 2000, 15:1298-1306
22. Shcherbak NS, Schwartz El: The C825T polymorphism in the G-protein β3 subunit gene and diabetic complications in IDDM patients Journal of Human Genetics 2001, 46:188-191
23. Shcherbak NS, Shutskaya ZhV, Sheidina AM, Larionova VI, Schwartz El: Methylenetetrahydrofolate Reductase Gene Polymorphism as a Risk Factor for Diabetic Nephropathy in IDDM Patients Molecular Genetics and Metabolism 1999, 68:375-378
24. Kimura H, Suzuki Y, Gejyo F, Karasawa R, Miyazaki R, Suzuki S, Arakawa M: Apolipoprotein E4 reduces risk of diabetic nephropathy in patients with NIDDM Am J Kidney Dis 1998, 31:666-673
25. Tamow L, Stehouwer CD, Emeis JJ, Poirier O, Cambien F, Hansen BV: Parving HH: Plasminogen activator inhibitor-1 and apolipoprotein E gene polymorphisms and diabetic angiopathy Nephrol Dial Transplant 2000, 15:625-630
26. Onuma T, Laffel LM, Angelico MC, Krolewski AS: Apolipoprotein E genotypes and risk of diabetic nephropathy J Am Soc Nephrol 1996, 7:1075-1078